ASTRAZENECA PLC share price logo

ASTRAZENECA PLC Share Price

NASDAQ: AZN

Mega Cap

$204.33

+3.52

(+1.75%)

as on

ASTRAZENECA PLC Stock Performance

as on April 9, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $203.66
    $206.73
    downward going graph

    0.33%

    Downside

    1.17%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $61.24
    $212.71
    downward going graph

    70.03%

    Downside

    4.10%

    Upside

    downward going graph

ASTRAZENECA PLC share price movements today

Previous Close
$200.81
Open
$205.09
Volume
1.5M
Day's Low - High
$203.66 - $206.73
52 Week Low - High
$61.24 - $212.71

ASTRAZENECA PLC Historical Returns

1 Month Return
+ 3.39 %
3 Month Return
+ 113.6 %
1 Year Return
+ 209.41 %
3 Year Return
+ 177.59 %
5 Year Return
+ 305.68 %

ASTRAZENECA PLC Stock Fundamentals & Key Indicators

Check ASTRAZENECA PLC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$314.4B

EPS (TTM)

5.1609

Dividend Yield

1.69%

Quarterly Earnings Growth YOY

0.54%

PE Ratio (TTM)

31.06

Industry PE ratio

26.88111111111111

PEG Ratio

1.6691

EBITDA

19.3B

Revenue (TTM)

58.7B

Profit Margin

17.41%

Return On Equity TTM

22.84%

ASTRAZENECA PLC Stock Valuation

Track how ASTRAZENECA PLC P/E has moved over time to understand its valuation trends.

ASTRAZENECA PLC in the last 5 years

  • Overview

  • Trends

Lowest (-90.30x)

March 31, 2022

Industry (26.88x)

April 8, 2026

Today (31.06x)

April 8, 2026

Highest (71.29x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 31.06x

ASTRAZENECA PLC vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ASTRAZENECA PLC with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
ASTRAZENECA PLC image
ASTRAZENECA PLC
BUY$314.4B305.68%31.0617.41%
Eli Lilly And Company image
Eli Lilly And Company
BUY$833.3B409.88%40.531.67%
Johnson & Johnson image
Johnson & Johnson
BUY$580.7B46.29%21.8528.46%
Abbvie Inc image
Abbvie Inc
BUY$365.6B94.51%87.586.91%
Merck & Co. Inc. image
Merck & Co. Inc.
BUY$298.8B58.01%16.628.08%

Stock Returns calculator for ASTRAZENECA PLC Stock including INR - Dollar returns

The ASTRAZENECA PLC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

ASTRAZENECA PLC investment value today

Current value as on today

₹3,37,054

Returns

₹2,37,054

(+237.05%)

Returns from ASTRAZENECA PLC Stock

₹2,14,838 (+214.84%)

Dollar Impact

₹22,216 (+22.22%)

Analyst Recommendation on ASTRAZENECA PLC Stock

Based on 38 analysts

BUY

81.58%

Buy

15.79%

Hold

2.63%

Sell

Based on 38 analysts, 81.58% of analysts recommend a 'BUY' rating for ASTRAZENECA PLC. Average target price of $209.89

ASTRAZENECA PLC Share Price Target

Get share price movements and forecasts by analysts on ASTRAZENECA PLC.

What analysts predicted

2.65%UPSIDE

Target Price

$209.89

Current Price

$204.33

Analyzed by

38 Analysts

Target

$209.89

ASTRAZENECA PLC target price $209.89, a slight upside of 2.65% compared to current price of $204.33. According to 38 analysts rating.

ASTRAZENECA PLC Stock’s Investor Sentiment and Interest

Investment in ASTRAZENECA PLC Shares on INDmoney has dropped by -23.40% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-23.40% versus previous 30 day period

Search interest for ASTRAZENECA PLC Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

ASTRAZENECA PLC Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
11,492
12,024
12,679
12,938
13,565
14,891
13,588
14,457
15,191
15,503
Gross Profit
9,397
9,716
10,461
10,755
10,484
12,166
11,347
11,984
12,390
12,385
Operating Income
1,954
1,234
3,115
2,746
2,106
2,036
3,674
3,508
3,583
2,978
EBITDA
3,326
2,669
4,468
4,119
4,102
2,809
5,035
4,955
5,227
4,612
Interest Expense
392
445
413
443
457
429
349
439
434
472
Depreciation
-
-
-
-
1,817
714
1,284
1,389
1,549
1,511
Income Before Tax
1,652
897
2,800
2,397
1,828
1,666
3,402
3,127
3,244
2,629
Income Tax Expense
274
-62
620
469
395
166
481
679
709
300
Net Income
1,374
960
2,179
1,927
1,429
1,500
2,916
2,450
2,533
2,326
Net Profit Margin
11.96%
7.98%
17.19%
14.89%
10.53%
10.07%
21.46%
16.95%
16.67%
15.00%

ASTRAZENECA PLC Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
23,002
22,465
22,090
24,384
26,617
37,417
44,351
45,811
54,073
58,739
Gross Profit
18,876
18,147
17,154
19,463
21,318
24,980
31,960
37,543
43,866
48,106
Operating Income
4,902
3,677
3,387
2,924
5,162
1,056
3,757
8,193
10,003
13,743
EBITDA
7,276
6,623
7,112
6,712
8,084
5,113
9,085
13,422
15,438
19,829
Interest Expense
1,367
1,360
1,366
1,402
1,272
1,276
1,330
1,589
1,682
1,694
Depreciation
-
-
-
-
-
4,102
5,254
4,934
5,065
5,733
Income Before Tax
3,552
2,227
1,993
1,548
3,916
-265
2,501
6,899
8,691
12,402
Income Tax Expense
146
-641
-57
321
772
-380
-792
938
1,650
2,169
Net Income
3,499
3,001
2,155
1,335
3,196
112
3,288
5,955
7,035
10,255
Net Profit Margin
15.21%
13.36%
9.76%
5.47%
12.01%
0.30%
7.41%
13.00%
13.01%
17.46%

ASTRAZENECA PLC Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
897
2,800
2,397
1,828
1,666
2,916
3,127
2,533
2,356
Operating Cash Flow
2,380
2,486
3,085
3,383
2,907
3,713
3,386
5,134
2,430
Investing Cash Flow
-1,077
-2,413
-2,872
-1,514
-1,181
-1,253
-2,108
-2,001
-1,521
Financing Cash Flow
-291
2,028
-1,222
-4,131
-671
-2,707
518
-2,078
-3,356
Change in Cash
1,018
2,055
-1,015
-2,242
994
-222
1,825
1,048
-2,410

ASTRAZENECA PLC Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
2,227
1,993
1,548
3,916
-265
2,501
6,899
8,691
10,225
Operating Cash Flow
3,578
2,618
2,969
4,799
5,963
9,808
10,345
11,861
14,575
Investing Cash Flow
-2,328
963
-657
-285
-11,058
-2,960
-4,064
-7,980
-6,808
Financing Cash Flow
-2,936
-2,044
-1,765
-2,203
3,649
-6,823
-6,567
-3,996
-7,544
Change in Cash
-1,752
1,499
552
2,323
-1,508
-55
-346
-208
269

Global Institutional Holdings in ASTRAZENECA PLC

Funds
Holdings
Neuberger Berman Group LLC
0.16%
Boston Partners Global Investors, Inc
0.16%
Bank of America Corp
1.01%
PRIMECAP Management Company
1.33%
Jennison Associates LLC
0.39%
See all

ASTRAZENECA PLC News & Key Events

    Insights on ASTRAZENECA PLC

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      AstraZeneca PLC has shown consistent revenue growth over the last four quarters, increasing from $13.58 billion to $15.50 billion. This represents an average increase of 4.3% in revenue each quarter, indicating a positive trend in the company's financial performance.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 months, AZN stock has moved up by 113.6%

    • imgPOSITIVE IMPACT

      Best in 1 Year

      img

      In the last 1 year, AZN has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, AZN has outperformed top 5 stocks with highest market-cap in its industry

    • imgNEGATIVE IMPACT

      Profit Down

      img

      AstraZeneca PLC has experienced a decline in net profit over the last two quarters, with profits decreasing from $2.53 billion to $2.32 billion. This represents an average decrease of 8.2% per quarter.

    About ASTRAZENECA PLC

    "AstraZeneca plc is an English pharmaceutical company located in Cambridge. It is a multinational pharmaceutical and biotechnology firm based in the United Kingdom and Sweden. The company operates in over 100 countries and caters to the requirements of millions of people globally. Among the significant ailments covered by the company's product range are oncology, gastrointestinal, infectious, respiratory, and inflammatory disorders. Astra AB and Zeneca Group Plc amalgamated to establish AstraZeneca in 1999. Astra AB was founded in 1913 by 400 Swedish doctors. Zeneca Group PLC was created in 1993 when the British chemicals business ICI (formed by the amalgamation of four British chemical companies) demerged its medicines, agrochemicals, and specialist divisions to become Zeneca Group PLC. The merger is one of the world's largest pharmaceutical businesses, having purchased several corporations, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013), and Definiens (by MedImmune in 2014). The organisation undertakes research and development in three strategic locations: England, Sweden, and Maryland, United States. The Oxford–AstraZeneca vaccine was approved for use in India in January 2021, paving the way for a large-scale vaccination campaign in the world's second-most populous country. The Serum Institute of India later stated that the Oxford–AstraZeneca shot would be manufactured locally under the brand name COVISHIELD. Currently ASTRAZENECA PLC has a market cap of $314.44 Billion. It has a P.E ratio of 31.06. The shares of ASTRAZENECA PLC are trading at {current share price in dollars (in INR)}."
    OrganisationASTRAZENECA PLC
    Headquarters1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA
    IndustryHealth Technology
    CEOMr. Pascal Claude Roland Soriot D.V.M., M.B.A.
    E-voting on sharesClick here to vote

    Key Management of ASTRAZENECA PLC

    Name

    Title

    Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.

    CEO & Executive Director

    Ms. Pam P. Cheng

    EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board

    Mr. Jeffrey Pott J.D.

    CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board

    Dr. Ruud Dobber Ph.D.

    Executive Vice-President of BioPharmaceuticals Business Unit

    Dr. Susan Mary Galbraith M.D., Ph.D.

    Executive Vice President of Oncology R&D

    Ms. Iskra Reic

    Executive Vice President of International

    Mr. David Fredrickson

    Executive Vice-President of Oncology Haematology Business Unit

    Ms. Ruth March

    Senior VP of Precision Medicine - R&D Oncology

    Dr. Aradhana Sarin M.D.

    CFO & Executive Director

    Mr. Joris Silon

    Head of Investor Relations

    FAQs

    What is ASTRAZENECA PLC share price today?

    ASTRAZENECA PLC share price today is $204.33 as on at the close of the market. ASTRAZENECA PLC share today touched a day high of $206.73 and a low of $203.66.

    What is the 52 week high and 52 week low for ASTRAZENECA PLC share?

    ASTRAZENECA PLC share touched a 52 week high of $212.71 on and a 52 week low of $61.24 on . ASTRAZENECA PLC stock price today i.e. is closed at $204.33,which is 3.94% down from its 52 week high and 233.65% up from its 52 week low.

    What is ASTRAZENECA PLC's market capitalisation today?

    ASTRAZENECA PLC market capitalisation is $0.31T as on .

    How to invest in ASTRAZENECA PLC Stock (AZN) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for ASTRAZENECA PLC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ASTRAZENECA PLC Shares that will get you 0.0073 shares as per ASTRAZENECA PLC share price of $204.33 per share as on April 9, 2026 at 1:29 am IST.

    What is the minimum amount required to buy ASTRAZENECA PLC Stock (AZN) from India?

    Indian investors can start investing in ASTRAZENECA PLC (AZN) shares with as little as ₹92.336 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹923.36 in ASTRAZENECA PLC stock (as per the Rupee-Dollar exchange rate as on ). Based on ASTRAZENECA PLC share’s latest price of $204.33 as on April 9, 2026 at 1:29 am IST, you will get 0.0489 shares of ASTRAZENECA PLC. Learn more about fractional shares .

    What are the returns that ASTRAZENECA PLC has given to Indian investors in the last 5 years?

    ASTRAZENECA PLC stock has given 305.68% share price returns and 24.79% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?